{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/ilmn-stock-analysis/",
 "dataUrl": "https://clearank.com/stock/ilmn-stock-analysis/data.json",
 "title": "Illumina Inc. (ILMN) Stock Forecast & Price Target (2026)",
 "description": "Is Illumina (ILMN) a Buy or Sell today? Get the latest AI trade setup, key support levels and risk analysis. Updated daily.",
 "headline": "Illumina Inc. (ILMN)",
 "published": "2026-09-07T09:12:06+00:00",
 "modified": "2026-09-11T17:36:54.453+00:00",
 "generated": "2026-09-11T20:01:30.431Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "ILMN",
  "name": "Illumina Inc.",
  "type": "Common Stock",
  "exchange": "NASDAQ",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Diagnostics & Research",
  "country": "United States",
  "website": "https://www.illumina.com"
 },
 "quote": {
  "price": 206.28,
  "previousClose": 201.27,
  "change": 5.01,
  "changePercent": 2.49,
  "open": 202.49,
  "high": 208.38,
  "low": 200.46,
  "volume": 39869,
  "averageVolume": 1540647,
  "marketCap": 30391770000,
  "fiftyTwoWeekHigh": 231.81,
  "fiftyTwoWeekLow": 88,
  "marketOpen": false,
  "asOf": "2026-09-11T17:36:53.000Z"
 },
 "statistics": {
  "pe": 37.620564,
  "eps": 5.35,
  "dividendYield": 0,
  "beta": 1.467,
  "priceToSales": 6.762744,
  "priceToBook": 10.708699,
  "revenueTtm": 4494000128,
  "grossMargin": null,
  "returnOnEquity": 0.32339
 },
 "technicals": {
  "rsi": 40.5,
  "macd": 2.93,
  "sma50": 200.3,
  "sma200": 153.56,
  "rsiSignal": "Neutral",
  "trend": "Bullish",
  "pricePosition": "Bullish",
  "macdSignal": "Bullish",
  "rating": "Bullish"
 },
 "analysis": {
  "rating": "Hold",
  "score": 59,
  "consensus": "Hold",
  "fairValue": 206.28,
  "analystTarget": 213,
  "analystCount": 20,
  "wallStreetConsensus": "Hold",
  "generatedAt": "2026-09-11T17:36:53.000Z",
  "priceAtAnalysis": 206.28,
  "volatility": {
   "daily": 2.95,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Neutral",
  "conservativeEntry": 204.22,
  "aggressiveEntry": 206.28,
  "stopLoss": 192.11,
  "stopLossPercent": 5.93,
  "targets": [
   210.34,
   214.43,
   220.55
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 124.86,
    "base": 215.15,
    "upside90th": 370.74
   },
   {
    "year": 2028,
    "downside10th": 103.95,
    "base": 224.4,
    "upside90th": 484.44
   },
   {
    "year": 2029,
    "downside10th": 91.2,
    "base": 234.05,
    "upside90th": 600.68
   },
   {
    "year": 2030,
    "downside10th": 82.21,
    "base": 244.12,
    "upside90th": 724.85
   },
   {
    "year": 2031,
    "downside10th": 75.41,
    "base": 254.61,
    "upside90th": 859.65
   },
   {
    "year": 2032,
    "downside10th": 70.03,
    "base": 265.56,
    "upside90th": 1007.04
   },
   {
    "year": 2033,
    "downside10th": 65.64,
    "base": 276.98,
    "upside90th": 1168.72
   },
   {
    "year": 2034,
    "downside10th": 61.99,
    "base": 288.89,
    "upside90th": 1346.38
   },
   {
    "year": 2035,
    "downside10th": 58.89,
    "base": 301.31,
    "upside90th": 1541.7
   },
   {
    "year": 2036,
    "downside10th": 56.23,
    "base": 314.27,
    "upside90th": 1756.44
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "ILMN Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$202.49",
    "Day Range": "$200.46 to $208.38",
    "Prev Close": "$201.27",
    "Volume": "39.9K",
    "52-Week Range": "$88.00 to $231.81",
    "Market Cap": "$30.39B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a significant premium to sector peers (+48%), suggesting market expectations for superior growth or market position."
   ]
  },
  {
   "id": "analysis",
   "title": "ILMN Analysis",
   "text": [
    "Illumina Inc.'s trading volume has been exceptionally low, registering at 398,690, which is a stark 97.4% below its average volume of 1,540,647. This low volume suggests a lack of conviction from market participants regarding the current price action. The stock is trading above its 50-day and 200-day moving averages ($200.30 and $153.56), indicating a generally upward long-term trend, but it is currently below its 20-day exponential moving average, pointing to short-term weakness. The Relative Strength Index (RSI) is at 40.5, which falls into the neutral momentum category, suggesting neither overbought nor oversold conditions. Key support levels are likely to be found around the 50-day SMA of approximately $200.30, while resistance may be encountered near the 20-day EMA at around $209.01. The stochastic oscillator is at 18.56, indicating a position closer to oversold territory, which could suggest a potential for a short-term bounce, but this is not confirmed by the RSI. The Commodity Channel Index (CCI) at -106.85 also points towards bearish momentum in the short term.",
    "Insiders have sold over $592 million in stock, far exceeding the $1.6 million in purchases, resulting in a 'Heavy Sell Signal' and raising concerns about management's confidence.",
    "The latest earnings report for July 2026 showed an EPS of -0.02 against an estimate of 0.04, a -150% surprise, leading to a price decline and highlighting execution challenges.",
    "The RSI is at 40.5, indicating neutral momentum, and the stock is trading below its 20-day EMA, suggesting a lack of immediate bullish technical signals.",
    "Revenue growth is projected to be around 6% for the current and next fiscal years, which may not be sufficient to justify the current premium valuation.",
    "The base case for Illumina Inc. over the next 6-12 months is cautious, given the significant insider selling and a premium valuation that is not fully supported by recent earnings performance or projected growth rates. While the stock is trading above key long-term moving averages, the neutral technical momentum and extremely low volume suggest a lack of immediate catalysts for a significant upward move. The median analyst price target of $213 implies only a marginal upside from the current price of $206.28. Potential upside could materialize if the company demonstrates a consistent return to strong earnings beats and if insider selling subsides, signaling renewed confidence. Conversely, continued earnings misses, a failure to accelerate revenue growth beyond the projected 6%, or further negative news regarding competitive pressures or regulatory scrutiny could pressure the stock lower, potentially testing the support around the 50-day SMA near $200.30."
   ],
   "lists": {
    "ProTips": [
     "Given the 'Heavy Sell Signal' from insiders, investors should closely monitor any further disclosures of insider transactions and consider the implications for management's confidence in the company's future prospects.",
     "The extremely low trading volume suggests a lack of market conviction; consider waiting for increased volume or clearer technical signals before initiating or adding to a position.",
     "With a P/E ratio significantly above the sector average and recent earnings misses, risk-averse investors may want to wait for a more attractive entry point or clearer signs of fundamental improvement."
    ]
   },
   "catalysts": [
    {
     "type": "Bearish",
     "title": "Heavy Insider Selling Pressure",
     "text": "Insiders have sold over $592 million in stock, far exceeding the $1.6 million in purchases, resulting in a 'Heavy Sell Signal' and raising concerns about management's confidence.",
     "source": "Insider Transactions Data"
    },
    {
     "type": "Bearish",
     "title": "Recent EPS Miss and Negative Surprise",
     "text": "The latest earnings report for July 2026 showed an EPS of -0.02 against an estimate of 0.04, a -150% surprise, leading to a price decline and highlighting execution challenges.",
     "source": "Earnings Report"
    },
    {
     "type": "Neutral",
     "title": "Neutral Technical Momentum",
     "text": "The RSI is at 40.5, indicating neutral momentum, and the stock is trading below its 20-day EMA, suggesting a lack of immediate bullish technical signals.",
     "source": "Technical Analysis"
    },
    {
     "type": "Neutral",
     "title": "Modest Revenue Growth Projections",
     "text": "Revenue growth is projected to be around 6% for the current and next fiscal years, which may not be sufficient to justify the current premium valuation.",
     "source": "Wall Street Revenue Estimates"
    }
   ],
   "links": [
    {
     "text": "CCI",
     "url": "https://clearank.com/stock/cci-stock-analysis/"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Illumina Inc. exhibits a Price-to-Earnings (P/E) ratio of 37.62, which is considerably higher than the sector average P/E of 25.5, suggesting the stock is trading at a premium relative to its peers. The Earnings Per Share (EPS) stands at $5.35. While the company's revenue growth is projected at approximately 6% for both the current and next fiscal years, this growth rate appears modest when compared to its elevated valuation multiples. The balance sheet strength is not explicitly detailed with debt-to-equity or cash figures, but the P/E ratio suggests that investors are pricing in significant future growth. The company's recent earnings performance, particularly the negative EPS surprise in the latest quarter, raises concerns about profitability execution. The premium valuation, coupled with mixed earnings and substantial insider selling, creates a risk-reward scenario that warrants careful consideration.",
    "Illumina Inc.'s most recent earnings report for the quarter ending July 2026 revealed a significant miss, with an actual EPS of -0.02 compared to an estimated 0.04, translating to a -150% surprise and a 1.84% decline in stock price. This follows a period of mixed performance, including a strong beat in April 2026 (1.15 actual vs. 1.05 estimate) and a substantial beat in February 2026 (0.43 actual vs. 0.16 estimate). The current revenue growth is estimated at 6.00% for the current quarter and 5.00% for the next quarter, indicating a slowdown in top-line expansion.",
    "The primary risk for Illumina Inc. is the significant insider selling, with over $592 million in sales against only $1.6 million in purchases, signaling a 'Heavy Sell Signal' from management. This heavy divestiture raises concerns about internal confidence in future performance. Additionally, the stock's P/E ratio of 37.62 is substantially higher than the sector average of 25.5, indicating a potentially overvalued stock given recent earnings misses and modest projected revenue growth. The neutral technical momentum, with an RSI of 40.5 and the stock trading below its 20-day EMA, suggests a lack of immediate upward catalysts."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "30.39B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "37.62"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "5.35"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "231.81"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "88.00"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bullish RSI Neutral SMA Cross Bullish Price vs SMA Bullish MACD Bullish Golden Cross in effect with the 50-day SMA ($200.30) above the 200-day SMA ($153.56), price action is firmly bullish above key moving averages."
   ],
   "facts": {
    "RSI": "Neutral",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bullish",
    "MACD": "Bullish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "40.50"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "2.93"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "200.30"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "153.56"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.38",
    "Correlation with Nasdaq 100 (QQQ)": "+0.34",
    "Correlation with Bitcoin (BTC)": "+0.27",
    "Correlation with Gold (XAU)": "+0.07"
   }
  },
  {
   "id": "trade-plans",
   "title": "ILMN Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Enter now if confident",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (40.5) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$210.34",
    "TARGET 2": "$214.43",
    "TARGET 3": "$220.55",
    "STOP LOSS": "$192.11"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "2.95%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in ILMN in September 2016 would be worth about $12,120 today, compared with about $35,030 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ILMN today could grow to about $15,235 by 2036 in the base case, with a bull case near $85,148 and a bear case around $2,726. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "ILMN Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $244 for ILMN by 2030 in the base case, from $206 today (1.2x over 4 years). The downside path ends near $82.21. These are outcomes of a Monte Carlo simulation run on ILMN's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using ILMN's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "ILMN simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$125",
        "$215",
        "$371"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$104",
        "$224",
        "$484"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$91.20",
        "$234",
        "$601"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$82.21",
        "$244",
        "$725"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$75.41",
        "$255",
        "$860"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$70.03",
        "$266",
        "$1,007"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$65.64",
        "$277",
        "$1,169"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$61.99",
        "$289",
        "$1,346"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$58.89",
        "$301",
        "$1,542"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$56.23",
        "$314",
        "$1,756"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "REGN Regeneron Pharmaceuticals, Inc. NASDAQ $793.26 -1.78%",
     "url": "https://clearank.com/stock/regeneron-regn/"
    },
    {
     "text": "OFIX Orthofix Medical Inc. NASDAQ $8.81 -1.12%",
     "url": "https://clearank.com/stock/ofix-stock-analysis/"
    },
    {
     "text": "OSCR Oscar Health, Inc. NYSE $31.84 +0.2361%",
     "url": "https://clearank.com/stock/oscr-stock-analysis/"
    },
    {
     "text": "RMD ResMed Inc. NYSE $216.92 -1.21%",
     "url": "https://clearank.com/stock/rmd-stock-analysis/"
    },
    {
     "text": "IONS Ionis Pharmaceuticals, Inc. NASDAQ $55.65 -0.6605%",
     "url": "https://clearank.com/stock/ions-stock-analysis/"
    },
    {
     "text": "SYK Stryker Corp. NYSE $270.01 -1.95%",
     "url": "https://clearank.com/stock/stryker-syk/"
    },
    {
     "text": "MDT Medtronic NYSE $90.78 -0.9223%",
     "url": "https://clearank.com/stock/medtronic-mdt/"
    },
    {
     "text": "AMGN Amgen Inc. NASDAQ $378.76 -0.9700%",
     "url": "https://clearank.com/stock/amgen-amgn/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "MU vs WDC Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/mu-vs-wdc/"
    },
    {
     "text": "GLD vs SLV Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/gld-vs-slv/"
    },
    {
     "text": "SCHD vs VIG Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/schd-vs-vig/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "ILMN Insider Trading Analysis",
   "facts": {
    "Bought": "$1.6M",
    "Sold": "$592.9M",
    "Insiders": "22",
    "Avg Transaction": "$27.0M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in ILMN",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Aug 5, 2026",
       "cells": [
        "MEISTER KEITH A Director",
        "Sell",
        "741.1K",
        "$148.2M"
       ]
      },
      {
       "label": "Aug 21, 2026",
       "cells": [
        "MEISTER KEITH A Director",
        "Sell",
        "679.6K",
        "$145.6M"
       ]
      },
      {
       "label": "Jun 1, 2026",
       "cells": [
        "MEISTER KEITH A Director",
        "Sell",
        "669.6K",
        "$107.0M"
       ]
      },
      {
       "label": "Aug 27, 2026",
       "cells": [
        "MEISTER KEITH A Director",
        "Sell",
        "375.9K",
        "$85.2M"
       ]
      },
      {
       "label": "Sep 4, 2026",
       "cells": [
        "MEISTER KEITH A Director",
        "Sell",
        "263.6K",
        "$57.2M"
       ]
      },
      {
       "label": "May 14, 2026",
       "cells": [
        "MEISTER KEITH A Director",
        "Sell",
        "329.5K",
        "$47.9M"
       ]
      },
      {
       "label": "Feb 16, 2021",
       "cells": [
        "FLATLEY JAY T Director",
        "Sell",
        "4.5K",
        "$2.3M"
       ]
      },
      {
       "label": "Feb 2, 2021",
       "cells": [
        "FLATLEY JAY T Director",
        "Sell",
        "4.0K",
        "$1.8M"
       ]
      },
      {
       "label": "Mar 2, 2021",
       "cells": [
        "FLATLEY JAY T Director",
        "Sell",
        "4.0K",
        "$1.8M"
       ]
      },
      {
       "label": "Aug 31, 2020",
       "cells": [
        "RAGUSA ROBERT P Officer",
        "Sell",
        "5.0K",
        "$1.8M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Illumina+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "What is Illumina Inc.'s current stock price and consensus rating?",
   "answer": "Illumina Inc. is currently trading at $206.28 per share. The consensus rating among Wall Street analysts is 'Hold', with a consensus score of 59 out of 100."
  },
  {
   "question": "What is the median analyst price target for Illumina Inc. stock?",
   "answer": "The median analyst price target for Illumina Inc. is $213.00, suggesting a potential upside of 3.3% from the current stock price of $206.28."
  },
  {
   "question": "What are the key risks facing Illumina Inc.?",
   "answer": "The most significant risk is the heavy insider selling, totaling over $592 million, which indicates a lack of confidence from management. The stock also trades at a premium valuation with a P/E ratio of 37.62 compared to the sector average of 25.5, and has shown mixed recent earnings performance."
  },
  {
   "question": "How has Illumina Inc. performed in its recent earnings reports?",
   "answer": "Illumina Inc. reported a significant EPS miss in its most recent quarter ending July 2026 (-0.02 actual vs. 0.04 estimate), resulting in a -150% surprise. Prior quarters showed mixed results with both beats and misses."
  },
  {
   "question": "What is the technical outlook for Illumina Inc. stock?",
   "answer": "Technically, Illumina Inc. shows neutral momentum with an RSI at 40.5. While the stock is above its 50-day and 200-day moving averages ($200.30 and $153.56), it is below its 20-day EMA, and trading volume is exceptionally low, suggesting a lack of strong conviction."
  },
  {
   "question": "How does Illumina Inc.'s valuation compare to its sector averages?",
   "answer": "Illumina Inc.'s P/E ratio of 37.62 is notably higher than the sector average of 25.5, indicating that the stock is trading at a premium. Projected revenue growth for the current and next year is around 6%."
  },
  {
   "question": "What does the insider transaction data suggest about Illumina Inc.?",
   "answer": "Insider transaction data reveals a 'Heavy Sell Signal,' with insiders selling over $592 million in stock compared to only $1.6 million in purchases. This significant net selling activity is a key concern for investors."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "REGN",
    "name": "Regeneron Pharmaceuticals, Inc. NASDAQ",
    "price": "$793.26",
    "change": "-1.78%",
    "url": "https://clearank.com/stock/regeneron-regn/"
   },
   {
    "ticker": "OFIX",
    "name": "Orthofix Medical Inc. NASDAQ",
    "price": "$8.81",
    "change": "-1.12%",
    "url": "https://clearank.com/stock/ofix-stock-analysis/"
   },
   {
    "ticker": "OSCR",
    "name": "Oscar Health, Inc. NYSE",
    "price": "$31.84",
    "change": "+0.2361%",
    "url": "https://clearank.com/stock/oscr-stock-analysis/"
   },
   {
    "ticker": "RMD",
    "name": "ResMed Inc. NYSE",
    "price": "$216.92",
    "change": "-1.21%",
    "url": "https://clearank.com/stock/rmd-stock-analysis/"
   },
   {
    "ticker": "IONS",
    "name": "Ionis Pharmaceuticals, Inc. NASDAQ",
    "price": "$55.65",
    "change": "-0.6605%",
    "url": "https://clearank.com/stock/ions-stock-analysis/"
   },
   {
    "ticker": "SYK",
    "name": "Stryker Corp. NYSE",
    "price": "$270.01",
    "change": "-1.95%",
    "url": "https://clearank.com/stock/stryker-syk/"
   },
   {
    "ticker": "MDT",
    "name": "Medtronic NYSE",
    "price": "$90.78",
    "change": "-0.9223%",
    "url": "https://clearank.com/stock/medtronic-mdt/"
   },
   {
    "ticker": "AMGN",
    "name": "Amgen Inc. NASDAQ",
    "price": "$378.76",
    "change": "-0.9700%",
    "url": "https://clearank.com/stock/amgen-amgn/"
   }
  ],
  "comparisons": [
   {
    "ticker": "MU vs WDC Comparison",
    "name": "",
    "url": "https://clearank.com/compare/mu-vs-wdc/"
   },
   {
    "ticker": "GLD vs SLV Comparison",
    "name": "",
    "url": "https://clearank.com/compare/gld-vs-slv/"
   },
   {
    "ticker": "SCHD vs VIG Comparison",
    "name": "",
    "url": "https://clearank.com/compare/schd-vs-vig/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "CPRT",
    "text": "Copart, Inc.",
    "url": "https://clearank.com/stock/cprt-stock-analysis/"
   },
   {
    "ticker": "LUGDF",
    "text": "Lundin Gold Inc",
    "url": "https://clearank.com/stock/lugdf-stock-analysis/"
   },
   {
    "ticker": "KEYS",
    "text": "Keysight Technologies, Inc.",
    "url": "https://clearank.com/stock/keys-stock-analysis/"
   },
   {
    "ticker": "BRO",
    "text": "Brown & Brown Inc.",
    "url": "https://clearank.com/stock/bro-stock-analysis/"
   },
   {
    "ticker": "SYY",
    "text": "Sysco Corp.",
    "url": "https://clearank.com/stock/syy-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "IMSR",
    "text": "↓ 9.79%",
    "url": "https://clearank.com/stock/terrestrial-energy-imsr/"
   },
   {
    "ticker": "SWKS",
    "text": "↑ 9.79%",
    "url": "https://clearank.com/stock/skyworks-solutions-swks/"
   },
   {
    "ticker": "EIGEN/USD",
    "text": "↑ 9.39%",
    "url": "https://clearank.com/crypto/eigen-usd-crypto-analysis/"
   },
   {
    "ticker": "EGLD/USD",
    "text": "↓ 9.23%",
    "url": "https://clearank.com/crypto/egld-usd-crypto-analysis/"
   },
   {
    "ticker": "AERO/USD",
    "text": "↑ 8.90%",
    "url": "https://clearank.com/crypto/aero-usd-crypto-analysis/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "A",
    "text": "Agilent Technologies Inc.",
    "url": "https://clearank.com/stock/agilent-technologies-a/"
   },
   {
    "ticker": "DHR",
    "text": "Danaher",
    "url": "https://clearank.com/stock/dhr-stock-analysis/"
   },
   {
    "ticker": "IDXX",
    "text": "IDEXX",
    "url": "https://clearank.com/stock/idxx-stock-analysis/"
   },
   {
    "ticker": "IQV",
    "text": "IQVIA Holdings Inc.",
    "url": "https://clearank.com/stock/iqvia-iqv/"
   },
   {
    "ticker": "NTRA",
    "text": "Natera, Inc.",
    "url": "https://clearank.com/stock/natera-ntra/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/09/ilmn-stock-analysis-2026-09.png",
     "url": "https://clearank.com/wp-content/uploads/2026/09/ilmn-stock-analysis-2026-09.png",
     "width": "1280",
     "height": "720",
     "caption": "Illumina, Inc. (ILMN) stock price analysis chart for September 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/ilmn-stock-analysis/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/ilmn-stock-analysis/",
        "name": "Illumina Inc. (ILMN) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/ilmn-stock-analysis/#webpage",
     "url": "https://clearank.com/stock/ilmn-stock-analysis/",
     "name": "Illumina Inc. (ILMN) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-09-07T09:12:06+00:00",
     "dateModified": "2026-09-11T17:36:54+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/09/ilmn-stock-analysis-2026-09.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/ilmn-stock-analysis/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "Illumina Inc. (ILMN) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-09-07T09:12:06+00:00",
     "dateModified": "2026-09-11T17:36:54+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Is Illumina (ILMN) a Buy or Sell today? Get the latest AI trade setup, key support levels and risk analysis. Updated daily.",
     "name": "Illumina Inc. (ILMN) Stock Forecast & Price Target (2026)",
     "@id": "https://clearank.com/stock/ilmn-stock-analysis/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/ilmn-stock-analysis/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/09/ilmn-stock-analysis-2026-09.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/ilmn-stock-analysis/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "Illumina Inc. (ILMN)",
   "tickerSymbol": "ILMN",
   "url": "https://clearank.com/stock/ilmn-stock-analysis/",
   "description": "AI-powered financial analysis for Illumina Inc. (ILMN) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NASDAQ",
   "offers": {
    "@type": "Offer",
    "price": 206.28,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/",
    "priceValidUntil": "2026-09-12"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is Illumina Inc.'s current stock price and consensus rating?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Illumina Inc. is currently trading at $206.28 per share. The consensus rating among Wall Street analysts is 'Hold', with a consensus score of 59 out of 100."
     }
    },
    {
     "@type": "Question",
     "name": "What is the median analyst price target for Illumina Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The median analyst price target for Illumina Inc. is $213.00, suggesting a potential upside of 3.3% from the current stock price of $206.28."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key risks facing Illumina Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The most significant risk is the heavy insider selling, totaling over $592 million, which indicates a lack of confidence from management. The stock also trades at a premium valuation with a P/E ratio of 37.62 compared to the sector average of 25.5, and has shown mixed recent earnings performance."
     }
    },
    {
     "@type": "Question",
     "name": "How has Illumina Inc. performed in its recent earnings reports?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Illumina Inc. reported a significant EPS miss in its most recent quarter ending July 2026 (-0.02 actual vs. 0.04 estimate), resulting in a -150% surprise. Prior quarters showed mixed results with both beats and misses."
     }
    },
    {
     "@type": "Question",
     "name": "What is the technical outlook for Illumina Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Technically, Illumina Inc. shows neutral momentum with an RSI of 40.5. While the stock is above its 50-day and 200-day SMAs, it is below its 20-day EMA, and trading volume is exceptionally low, suggesting a lack of strong conviction."
     }
    },
    {
     "@type": "Question",
     "name": "How does Illumina Inc.'s valuation compare to its sector averages?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Illumina Inc.'s P/E ratio of 37.62 is notably higher than the sector average of 25.5, indicating that the stock is trading at a premium. Projected revenue growth for the current and next year is around 6%."
     }
    },
    {
     "@type": "Question",
     "name": "What does the insider transaction data suggest about Illumina Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insider transaction data reveals a 'Heavy Sell Signal,' with insiders selling over $592 million in stock compared to only $1.6 million in purchases. This significant net selling activity is a key concern for investors."
     }
    }
   ]
  }
 ]
}